3.1.10.3. azathioprine. mycophenolate routinely used primary therapy place azathioprine units worldwide. comparison azathioprine, mycophenolate reduced rejection rates significantly prospective randomised trials [243,244,246,285-289]. although large, prospective study found azathioprine may give acceptable results low-risk population , azathioprine usually reserved patients cannot tolerate mpa . added dual therapy cyclosporine steroids, meta-analysis found significant benefit azathioprine respect major outcome parameters . recommendationstrength ratingazathioprine may used low-risk population immunosuppressive drug, especially intolerant mycophenolate formulations.weak